Synapse - Gastrointestinal Oncology Service

Results (4744)

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated overall survival analysis with 29-month follow-up of NAPOLI 3

Meeting Abstract

Hussein, M. A.; Khan, G.; Chandana, S. R.; Cid, R. A. P.; Kiss, I.; Gallego, J.; Macarulla, T.; De la Fouchardiere, C.; Goetze, T.; Dean, A. P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study

Meeting Abstract

Pant, S.; Fan, J.; Oh, D. Y.; Choi, H. J.; Kim, J. W.; Chang, H. M.; Bao, L.; Sun, H. C.; Macarulla, T.; Xie, F.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Final results of a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC (MOUNTAINEER)

Meeting Abstract

Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J. M.; Coveler, A. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4-year follow-up of CheckMate 649

Meeting Abstract

Elimova, E.; Shitara, K.; Moehler, M. H.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo, C.; Wyrwicz, L. S.; Yamaguchi, K.; Cleary, J. M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01

Meeting Abstract

Fan, J.; Bekaii-Saab, T. S.; Aldrighetti, L. A.; Bridgewater, J. A.; Ferrone, C. R.; Harding, J. J.; Ikeda, M.; Knox, J. J.; Wang, J. L.; Kayhanian, H.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

GEMINI-Hepatobiliary: A phase 2 study of novel first-line immuno-oncology-based treatments in patients with advanced hepatobiliary cancers

Meeting Abstract

Zhou, J.; Cheng, A. L.; Ikeda, M.; Lim, H. Y.; Akce, M.; Qin, S.; Oh, D. Y.; Chan, S. L.; Xiang, J.; Qu, X.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Final overall survival results from phase 3 SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma

Meeting Abstract

Shitara, K.; Van Cutsem, E.; Lordick, F.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Xu, R. H.; Lonardi, S.; Yamaguchi, K.; Hung, Y. P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Botensilimab plus balstilimab in microsatellite stable metastatic colorectal cancer: Assessing efficacy in non-liver metastatic sites

Meeting Abstract

Fakih, M.; Bullock, A. J.; Schlechter, B. L.; Tsimberidou, A. M.; Messersmith, W. A.; Pimentel, A.; Balmanoukian, A. S.; Sanborn, R. E.; Segal, N. H.; Bockorny, B.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM)

Meeting Abstract

Tsang, E. S.; Shi, Q.; Olive, K. P.; Collisson, E. A.; Dixon, J. G.; Cusnir, M.; Winograd, R.; Botta, G. P.; Wadlow, R. C.; Shergill, A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies

Meeting Abstract

Park, Y. H.; Cortes, J.; Modi, S.; Hurvitz, S. A.; Bianchini, G.; Iwata, H.; Shitara, K.; Siena, S.; Goto, Y.; Ku, G. Y.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save